You're reading the free version. Trader adds the live tape and alerts.
Start tracking
BBIO Sale Disclosure
Kumar Neil · SEC Form 4 · Filed Jun 8, 2026
Sale
Calculated transaction value
$95.35K
Kumar Neil Chief Executive Officer
BBIO
BridgeBio Pharma
BBIO
Transaction date
Jun 4, 2026
Public filing date
Jun 8, 2026
Filing lag
Filed 4 days later
BBIO daily price context
Close on/before transaction
$67.33
Jun 4, 2026
First close after public filing
$67.68
Jun 9, 2026
30-day return after filing
+15.74%
Through Jul 8, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,429 shares @ $66.72
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001470831-26-000523
Filing cohort
Transactions in this filing
Showing 14 of 14
Trades
14
Issuers
1
Estimated value
$5.41M
Buys / sales
0 / 14
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Bridgebio Pharma, Inc. BBIO | Sale | Jun 5, 2026 | $304.52K |
| Bridgebio Pharma, Inc. BBIO | Sale | Jun 5, 2026 | $480.34K |
| Bridgebio Pharma, Inc. BBIO | Sale | Jun 5, 2026 | $572.74K |
| Bridgebio Pharma, Inc. BBIO | Sale | Jun 5, 2026 | $304.46K |
| Bridgebio Pharma, Inc. BBIO | Sale | Jun 5, 2026 | $480.27K |
| Bridgebio Pharma, Inc. BBIO | Sale | Jun 5, 2026 | $572.74K |
| Bridgebio Pharma, Inc. BBIO Current | Sale | Jun 4, 2026 | $95.35K |
| Bridgebio Pharma, Inc. BBIO | Sale | Jun 4, 2026 | $144.58K |
| Bridgebio Pharma, Inc. BBIO | Sale | Jun 4, 2026 | $1.08M |
| Bridgebio Pharma, Inc. BBIO | Sale | Jun 4, 2026 | $1.08M |
| Bridgebio Pharma, Inc. BBIO | Sale | Jun 4, 2026 | $30.72K |
| Bridgebio Pharma, Inc. BBIO | Sale | Jun 4, 2026 | $144.58K |
| Bridgebio Pharma, Inc. BBIO | Sale | Jun 4, 2026 | $95.35K |
| Bridgebio Pharma, Inc. BBIO | Sale | Jun 4, 2026 | $30.72K |